California Bill to Legalize Psychedelic Treatment Centers Fails

May 21, 2024 · Ganjapreneur

The California proposal to legalize treatment centers for therapeutic psychedelics has failed for the year after Democrats in the Senate Appropriations Committee last week dropped it alongside hundreds of bills, the LA Times reports. Senate Bill 1012 or the “Regulated Psychedelic Facilitators Act,” sponsored by state Sen. Scott Wiener (D), sought to legalize treatment centers where adults aged 21+ could have supervised access to psychedelic substances including psilocybin, psilocin, DMT, MDMA, and mescaline. Weiner’s attempt this year at psychedelic reforms in California was a… Read more.

Poll Finds Majority Support for Recriminalizing Cannabis In Thailand

May 20, 2024 · Ganjapreneur

A recent opinion survey by the National Institute of Development Administration in Thailand found that the majority of Thais support the government’s plan to relist cannabis as an illegal drug under federal law, the Bangkok Post reports. The poll found more than 75% majority support for the recriminalization plan, which was announced earlier this year by the health minister and then endorsed on social media this month by the prime minister. Conducted on May 14-15, the poll asked 1,310 people aged 15 and older for their… Read more.

Alaska to create task force to prepare state for MDMA therapy

May 20, 2024 · Green Market Report

The Alaska legislature passed a bill to establish a task force that will help prepare the state for potential federal legalization of psychedelic therapies, officials said. The task force won’t take a stance on whether psychedelic treatments are beneficial, said Rep. Jennie Armstrong, an Anchorage Democrat who introduced the House version of the bill that passed on May 10, but it aims to ensure the state is ready if the U.S. Food and Drug Administration approves such therapies, she said. The FDA is expected… Read more.

MSO Stocks Soar After Biden Video Confirms Cannabis Is Moving to Schedule III

May 20, 2024 · High Times

Cannabis stocks spiked immediately after President Joe Biden announced the reclassification of cannabis from a Schedule I to a Schedule III drug, endorsing the Justice Department’s recommendation.  Biden posted a video on X at 1 p.m. May 16, declaring that the U.S. Department of Justice would indeed reclassify cannabis, and within hours, cannabis-related stocks began rising amid the growing excitement. “Today’s step is another historic step moving forward,” Poseidon Investment Management co-founder Emily Paxhia told Yahoo! Finance on an episode of Market Domination.… Read more.

How Potent is Illegal Weed – THC Levels Tested Out at A. 58% B. 31% C. 16% D. 8%?

May 19, 2024 ·

The average THC potency of illegal weed is only 16%, same as legal cannabis says DEA? In the ever-changing landscape of cannabis, a striking revelation has come from the U.S. Drug Enforcement Administration (DEA). A recent statement established that the average potency of illicit marijuana flower stands at a industry standard of 16%. Understanding the implications of such a percentage requires a deeper dive into the realm of cannabinoids, particularly THC (tetrahydrocannabinol).  The Evolution of THC Potency THC is the main psychoactive compound in marijuana, responsible for… Read more.

Twenty-One of 27 European Union Countries Legalized Medical Cannabis, Report Highlights

May 18, 2024 · High Times

Medical cannabis is taking over Europe, as well as efforts to decriminalize cannabis in numerous countries and at local levels. In a pattern similar to what took place in the U.S., European nations are legalizing cannabis for medical or recreational purposes in a patchwork of new laws. According to a May 16 press release from Victoria, Australia-based Biortica Agrimed, 21 out of 27 member states of the European Union (EU) legalized medical cannabis. “The EU situation with respect to legalisation can best be… Read more.

Survey Shows Gen Z Likes Smoking Cannabis More than Drinking Alcohol

May 17, 2024 · MG Magazine

A recent study conducted by Veriheal reveals a significant trend among Gen Z favoring cannabis over alcohol and tobacco. The survey, which gathered responses from thousands of Veriheal patients between March 2023 and April 2024, shows 60 percent of Gen Z adult individuals rarely or never consume alcohol, preferring cannabis instead. Young adults who reported a preference for cannabis over alcoholic beverages cited the desire for happiness, relaxation, and pain relief as their main reasons for using cannabis.  While older generations may… Read more.

Marijuana Companies Want Court Hearing In Case Challenging Federal Prohibition To Be Streamed Online Next Week

May 17, 2024 · Marijuana Moment

Major marijuana companies are asking a federal court to grant remote public access to a hearing next week in a case where they’re seeking to shield in-state cannabis activity from federal enforcement. And the Justice Department says it has “no position” on the request. The hearing before the U.S. District Court for the District of Massachusetts’s Western Division is scheduled to take place on Wednesday. Attorneys for the plaintiffs stressed in a motion filed on Friday that the “dispute involves questions… Read more.

Industry Reaction to President Biden’s Cannabis Rescheduling

May 17, 2024 · Cannabis Now

President Joe Biden confirmed May 16, 2024, that the Department of Justice (DOJ) and Drug Enforcement Administration’s (DEA) has definitive plans to reclassify marijuana from a Schedule I to Schedule III drug under the Controlled Substances Act (CSA). Cannabis has been classified as Schedule I since 1970. Matt Darin, CEO of Curaleaf, the New York-based retailer operating cannabis dispensaries in 19 states, calls yesterday’s news “another important milestone in this very important process as we get closer to rescheduling cannabis… Read more.

President Biden Announces Federal Government Will Reschedule Cannabis in ‘Monumental’ Announcement

May 16, 2024 · High Times

President Joe Biden announced that the U.S. Department of Justice will officially reschedule cannabis, moving it from Schedule I, reserved for dangerous drugs with no medical value, to Schedule III. The news follows the historic announcement on April 30, that the U.S. Drug Enforcement Administration (DEA), will move to reclassify cannabis under Schedule III, the Associated Press reported. Biden, along with Vice President Kamala Harris, both recorded videos of the announcement and posted them on social media. “This is monumental,” Biden said… Read more.